Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma

This study has been terminated.
(because of safety concerns the study was terminated prematurely)
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Sanofi
Information provided by:
Arbeitsgemeinschaft medikamentoese Tumortherapie
ClinicalTrials.gov Identifier:
NCT00735345
First received: August 13, 2008
Last updated: October 6, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)